• Contact us
  • FAQs
AlmirallShare
  • About us
  • Collaboration Opportunities
  • What we offer
  • In numbers
  • News
  • Login
  • About us
  • Collaboration Opportunities
  • What we offer
  • In numbers
  • News
  • Contact us
  • FAQs
AlmirallShare
Login AlmirallShare

Stay in the loop

Subscribe to our latest news

Home > preclinical model

Published on


Related News

Published on 20/07/2022

AlmirallShare 7th call is out now!

AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases

Read More
Published on 20/05/2022

Innovative therapies for vitiligo

Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo

Read More

Related News

Published on 20/03/2022

Understanding hidradenitis suppurativa

Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa

Read More
Published on 20/01/2022

Glue degraders for skin diseases

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

Read More
Published on 05/07/2021

BIOMAP: Understanding inflammatory skin conditions

Almirall joins BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) as a new partner

Read More

Share
AlmirallShare

Science Partner

  • About us
  • Collaboration Opportunities
  • What we offer
  • In numbers
  • News
  • FAQs
Get in Touch

Any questions or comments about opportunities for collaboration?

Contact Us

© 2020 AlmirallShare
Jul 2020 | HQ-NOP-2000138

  • Terms of use
  • Privacy Policy
  • Cookies Policy